Ads
related to: Fda and Investors
Search results
FDA announces recall of heart pumps linked to deaths and injuries
CBS News· 3 days agoA pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA's...
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Benzinga via Yahoo Finance· 10 hours agoFollowing an investigation announced in November last year, the FDA said on Thursday that it would...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 9 hours agoYou can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights. On December 8, 2023, bluebird ...
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration - HOOKIPA Pharma...
Benzinga· 1 week agoFood & Drug Administration (FDA) and the European Medicines Agency (EMA). HOOKIPA and the FDA have aligned on the ...
BiVictriX Therapeutics AML treatment granted orphan drug status by FDA
Proactive Investors· 3 days agoBiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) told investors that the US Food and Drug...
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
InvestorPlace· 3 days agoIn the biotech and pharmaceutical world, FDA approval is the number one needle mover for drug...
NutraCast: Navigating pitfalls and exploring opportunities: What dietary supplements entrepreneurs...
Nutraingredients.com· 13 hours agoBrian Yam, vice president of regulatory affairs and quality assurance at Blue Ocean Regulatory, said...
...Raises $56.5M in Growth Funding To Build Connected AED Network and Transform Cardiac Arrest...
Coronado Eagle & Journal· 1 day agoAvive has rapidly built an expansive and diverse customer base, delivering its FDA approved and award-winning AED technology to organizations ...
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
Benzinga via Yahoo Finance· 1 day agoThe FDA has identified this as a Class I recall, the most severe type of recall. An investigation...
FDA clears Ocugen's Phase 3 trial for rare retinal disease therapy
Investing.com· 2 weeks agoOcugen, Inc. (NASDAQ: NASDAQ: OCGN ), a biotechnology firm, announced today that the U.S. Food and...